Discuss This Disease

4 free views remaining today

lung mucoepidermoid carcinoma

ICD-10 Codes

Related ICD-10:

Description

Mucoepidermoid Carcinoma of the Lung: A Rare and Diagnostic Challenge

Mucoepidermoid carcinoma (MEC) of the lung is a rare form of lung cancer that accounts for less than 1% of all lung malignancies [10]. It is classified under the group of lung carcinomas of the salivary gland type, which also includes adenoid cystic carcinoma and other subtypes [8].

Characteristics and Classification

MEC of the lung is a malignant tumor that originates from the submucosal bronchial glands. It is characterized by the presence of mucin-secreting cells, squamous cells, and intermediate-type cells [10]. The classification of MEC into low-grade and high-grade based on histological features has been proposed [4].

Incidence and Epidemiology

Pulmonary mucoepidermoid carcinoma (PMEC) is the most common malignant salivary gland tumor in the lungs, accounting for 0.1-0.2% of all lung malignancies in adults [15]. However, it has no specific epidemiological or clinical characteristics that distinguish it from other forms of lung cancer.

Diagnostic Challenges

Primary mucoepidermoid carcinomas (MEC) of the lung are rare and represent a diagnostic challenge due to their rarity and similarity in appearance to other types of lung tumors [13].

Key Points:

  • Mucoepidermoid carcinoma of the lung is a rare form of lung cancer.
  • It accounts for less than 1% of all lung malignancies.
  • MEC of the lung originates from the submucosal bronchial glands.
  • The classification of MEC into low-grade and high-grade based on histological features has been proposed.
  • PMEC is the most common malignant salivary gland tumor in the lungs, accounting for 0.1-0.2% of all lung malignancies in adults.

References:

[10] Mucoepidermoid carcinomas are rare salivary gland-type tumors that comprise mucin-secreting cells, squamous cells, and intermediate-type cells

Additional Characteristics

  • Mucoepidermoid carcinoma (MEC) of the lung is a rare form of lung cancer.
  • It accounts for less than 1% of all lung malignancies.
  • MEC of the lung originates from the submucosal bronchial glands.
  • The classification of MEC into low-grade and high-grade based on histological features has been proposed.
  • Pulmonary mucoepidermoid carcinoma (PMEC) is the most common malignant salivary gland tumor in the lungs, accounting for 0.1-0.2% of all lung malignancies in adults.

Signs and Symptoms

Common Signs and Symptoms of Lung Mucoepidermoid Carcinoma

Lung mucoepidermoid carcinoma, a rare type of cancer, can present with various symptoms that may be similar to those of more common lung conditions. The most common presenting symptoms are:

  • Cough: A persistent cough is often the first symptom, which can be dry or productive (

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Lung Mucoepidermoid Carcinoma

Lung mucoepidermoid carcinoma (MEC) is a rare and challenging type of cancer to diagnose. To make an accurate diagnosis, several diagnostic tests and procedures can be used.

  • Imaging Techniques: Chest X-ray, CT-scan, MRI, and PET scans are commonly used imaging techniques to assess the extent of the tumor and detect any metastases [7]. These tests can help identify the location and size of the

Additional Diagnostic Tests

  • Chest X-ray
  • MRI
  • PET scans
  • CT-scan

Treatment

Based on the search results, it appears that there is limited information available on the drug treatment of lung mucoepidermoid carcinoma.

However, according to search result [4], "There is no standard treatment for advanced MEC of the lung." This suggests that there may not be a widely accepted or established drug treatment protocol for this specific type of cancer.

On the other hand, search result [8] mentions that surgical resection is the primary treatment for pulmonary mucoepidermoid carcinoma, but does not specifically mention drug treatment. However, it also states that "there has been no standardized treatment strategy" for this condition, which may indicate a lack of established drug treatments.

It's worth noting that search result [1] mentions that surgery is the mainstay of treatment for low-grade mucoepidermoid carcinoma, but does not specifically mention drug treatment. However, it also states that "rarely requires adjuvant therapy", which could imply that some form of additional treatment may be used in certain cases.

Overall, based on the available information, it appears that there is limited or no established drug treatment protocol for lung mucoepidermoid carcinoma. However, this should not be taken as a definitive answer, and further research or consultation with a medical professional would be necessary to determine the most appropriate course of treatment.

There is no standard treatment for advanced MEC of the lung. [4] Surgical resection is the primary treatment for pulmonary mucoepidermoid carcinoma, but there has been no standardized treatment strategy. [8] Rarely requires adjuvant therapy. [1]

Recommended Medications

  • Limited or no established drug treatment protocol
  • Surgical resection and adjuvant therapy may be used in certain cases

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Lung Mucoepidermoid Carcinoma

Lung mucoepidermoid carcinoma (MEC) is a rare form of lung cancer that can be challenging to diagnose due to its similarity with other types of lung tumors. The differential diagnosis for lung MEC includes:

  • Adenocarcinoma: This type of lung cancer lacks squamous and intermediate cells, which are characteristic of MEC [6]. Adenocarcinomas also tend to express TTF1 (thyroid transcription factor 1) [6].
  • Adenosquamous carcinoma: This type of lung cancer is usually peripheral in location and does not contain the same proportion of epidermoid, mucous, and intermediate cells as MEC [6]. Adenosquamous carcinomas also tend to have a different histological appearance.
  • Pulmonary adenoid cystic carcinoma (PACC): PACC is another rare type of lung cancer that can be difficult to distinguish from MEC. However, PACC tends to have a more uniform and glandular architecture [1].
  • Adenoid cystic carcinoma: This type of cancer is typically found in the salivary glands but can also occur in the lungs. It has a distinct histological appearance with cribriform or tubular patterns [5].

Key Features for Differential Diagnosis

To differentiate lung MEC from other types of lung tumors, the following features should be considered:

  • Histological architecture: Lung MEC tends to have a mixture of epidermoid, mucous, and intermediate cells, whereas adenocarcinomas lack these cell types [5].
  • Cellular composition: The proportion of epidermoid, mucous, and intermediate cells can vary in lung MEC, but adenoid cystic carcinomas tend to have a more uniform glandular architecture [4].
  • Location: Lung MEC is typically found in the central airways, whereas adenosquamous carcinomas are usually peripheral in location [6].

References

[1] by X Li · 2018 · Cited by 18 — Pulmonary mucoepidermoid carcinoma (PMEC) and pulmonary adenoid cystic carcinoma (PACC) are usually considered to originate from the bronchial glands of minor ...

[2] by YQ Wang · 2015 · Cited by 35 — Low-grade MEC can be considered in the differential diagnosis if moderate to marked enhancement is observed in homogeneous bronchial nodules or masses, ...

[3] by S Alsidawi · 2013 · Cited by 32 — Mucoepidermoid carcinoma (MEC) of the lung is a rare form of lung cancer that is classified into low grade and high grade based on histological features.

[4] by X Li · 2018 · Cited by 18 — Pulmonary mucoepidermoid carcinoma (PMEC) and pulmonary adenoid cystic carcinoma (PACC) are usually considered to originate from the bronchial glands of minor ...

[5] by AC Roden · 2014 · Cited by 109 — Mucoepidermoid carcinomas were morphologically defined by the presence of variable proportions of epidermoid, mucous and intermediate cells in ...

[6] Dec 20, 2023 — Differential diagnosis. Adenocarcinoma: lacks squamous and intermediate cells; TTF1+ · Adenosquamous carcinoma: usually peripheral in lung, not ...

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2014-10-21T15:13:36Z
oboInOwl#id
DOID:0050932
core#notation
DOID:0050932
IAO_0000115
A lung carcinoma that has_material_basis_in a combination of squamous cells, mucus secreting cells and intermediate cells.
rdf-schema#label
lung mucoepidermoid carcinoma
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_cancer_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_3905
relatedICD
http://example.org/icd10/C34.30
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_966
owl#annotatedSource
t336851

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.